万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://www.kidney-international.org/
https://www.journals.elsevier.com/kidney-international
3、投稿网址：https://mc.manuscriptcentral.com/ki
4、官网邮箱：pmorriss@wustl.edu
5、期刊刊期：月刊，一年出版12期。
2021年8月5日星期四
投稿须知【官网信息】
Kidney International
Guide for Authors
Informed consent and patient details
Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.
Note: Manuscripts should be organized under the following 11 headings, with the Methods appearing BEFORE the Results: Graphical Abstract, Title page, Abstract, Translational Statement (only for Basic Research articles), Introduction, Methods, Results, Discussion, Disclosure statement, References, and Acknowledgements.
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Please add your Twitter Handle (“@+twitter user name”) and ORCID (Open Researcher and Contributor ID) to your user account in manuscript central. If you don’t have an ORCID, you can sign up for free at https://orcid.org/.
Frequency
Published monthly.
Impact factor
2019 Impact Factor: 8.945
6 of 85 journals in Urology & Nephrology
© 2020 Clarivate Analytics
ISSN
ISSN: 0085-2538
EISSN: 1523-1755
Abstracted/indexed in
Index Medicus/Medline, Science Citation Index, Current Contents/Life Sciences, Current Contents/Clinical Medicine, SciSearch, BIOSIS, Chemical Abstracts, EMBASE, Reference Update, CABS, Biological Abstracts, Global Health, Adonis, PASCAL, Scopus
Publication charges
Page charges cover a proportion of the costs of processing and producing the article for publication. After final layout for publication, each page of basic research, brief report, clinical investigation, clinical trial, and technical notes articles will incur a fixed charge of US$165 per page.
Page charges do not apply to invited articles (commentaries, controversies in nephrology, editorials, mini reviews, nephrologists sans frontiers, reviews, policy forums, practice guidelines, and xyz of statistics).
Scope
Kidney International devotes itself to renal research. It aims to inform the renal researcher and the practicing nephrologist on all aspects of renal research. These include the latest clinical studies on emerging developments in renal medicine and the highest level of original research studies in clinical and basic renal research. In each issue some of these articles will be highlighted by commentaries that aim to put these studies in the appropriate context. These will form a research tool for clinical and basic investigators. Nephrology Digest comments and puts in perspective several areas of new developments in basic and clinical research in nephrology at large, as reported in the recent literature and at scientific meetings. Editorials highlight important issues in international nephrology. Nephrology sans Frontières are occasional short articles that discuss matters of local interest to nephrologists around the world, but which we feel need to be known by nephrologists worldwide. In-depth reviews are about major issues in renal research and controversial discussions on renal therapeutics or diagnosis written by two opposing authorities. Nephrology Images are presentations of interesting images in renal pathology; radiology chosen for their illustrative nature or simply for their esthetic qualities; issues of importance to the international renal community, including the politics of funding, of organ transplantation, of adequacy of dialysis, of worldwide affordability of end-stage renal care, and many other topical issues. Journal Club is a synopses that brings you the latest research highlights from across a wide spectrum of journals in fields relevant to renal research.
Reporting Guidelines
KI requires authors to completely, accurately, and transparently report their findings. Authors submitting articles to KI should refer to the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) Network website (http://www.equator-network.org/), which provides a central repository of reporting guidelines and other resources to assist authors.
Authors of the following study types are required to upload a copy of the corresponding checklist with their manuscript:
CONSORT checklist and flow diagram for Randomized clinical trials
STROBE checklist for Observational Studies (see modified STROBE Statement)
PRISMA checklist and flow diagram for Systematic reviews and meta-analyses—interventional studies
MOOSE checklist and flow diagram for Systematic reviews and meta-analyses—observational studies
STARD checklist and flow diagram for Diagnostic accuracy studies
COREQ for Qualitative research
TRIPOD for Development and updating of predictive models
CHEERS for Economic evaluation
STARI statement and checklist for Implementation studies
STREGA Checklist for studies that investigate Associations between genetic factors and clinical measurements or disease outcomes.
These checklists help improve the quality and consistency of data reporting and assist reviewers in assessing the manuscript. Missing items or deviations should be explained by the authors.
KI encourages the use of PENELOPE for help with identification of the appropriate checklist for data reporting. This tool can be found at http://www.peneloperesearch.com/equatorwizard.
Peer Review
This journal operates a single blind review process. All contributions will be initially assessed by the editor for suitability for Kidney International. Papers deemed suitable are then sent to at least two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. For more information on the types of peer review, please visit our peer-review site (https://www.elsevier.com/reviewers/peer-review).
Editor Disclosures
Kidney International follows the ICMJE Guidelines for Disclosures and Conflicts of Interest. Editors and editorial staff must not use information gained through working with manuscripts for private gain. Editor disclosure forms about potential conflicts of interests related to their own commitments are collected annually and kept on file in the editorial office. Authors and reviewers who require this information should contact the editorial office staff.
PREPARATION OF MANUSCRIPTS
Note: Manuscripts should be organized under the following 11 headings, with the Methods appearing BEFORE the Results: Graphical Abstract, Title page, Abstract, Translational Statement (only for Basic Research articles), Introduction, Methods, Results, Discussion, Disclosure statement, References, and Acknowledgements.
The American Medical Association Manual of Style (10th edition) should be used as a style guideline.
Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
Types of articles
Review
Word limit: Reviews should be between 3,000 and 5,000 words, and on average 4,000 words, including abstract but excluding references, tables, and figures.
Abstract: 250 words maximum.
References: 150 maximum.
Figures/tables: 1–3 images or figures required.
Disclosure statement required.
Reviews are comprehensive analyses of specific topics in nephrology that are solicited by the Editors. Proposals for reviews should be submitted to the editorial office by email: pmorriss@wustl.edu. Authors should only send an outline of the proposed paper for initial consideration. Unsolicited reviews submitted directly to Manuscript Central will not be considered. All invited review articles will undergo peer review prior to decision, and there is no absolute guarantee of acceptance.
Original Article
Subcategories: Basic Research, Clinical Investigation.
Word limit: 4,000 words (22,400 characters) maximum including spaces and abstract but excluding references, tables, and figures. Abstract: 250 words (1,500 characters) maximum including spaces. Results: Include headings about what is being tested in each individual experiment.
References: no limit.
Figures/tables: no limit. However, additional figures and tables may be considered as supplements for web-only publication.
Disclosure statement required. Full-length reports of current research in either basic or clinical science.
Data Sharing Statement—Large biological datasets
Graphical Abstract required. See Graphical Abstract section for more details.
Systematic Reviews: submit as an Original Article. Include PRISMA checklist and PRISMA flow diagram with submission.
Brief Report
The purpose of the Brief Report format is to publish concise but complete reports that present high-quality findings of exceptional interest, novelty, and broad significance for the readers of Kidney International. Case Reports and Case series will not be reviewed unless they provide groundbreaking insights.
A manuscript considered as a potential Brief Report by the Editors will be sent to referees with a request of rapid review. If the manuscript is deemed interesting but not of sufficiently transformative potential, authors may be asked to resubmit their revision as a regular article.
Brief Reports differ from regular articles in that they should be arranged in the following order:
Title page,
Abstract and keywords,
Introduction,
Short Methods,
Results,
Discussion (no headings necessary),
Acknowledgments,
References,
Tables (each including a title and legend), and
Figure legends.
The abstract should be brief (3 sentences, no more than 100 words). The main text should be limited to 1,500 words (including the abstract but not the acknowledgments, references, tables, and figure legends). Brief Reports normally have no more than 2 display items (Figure and/or Table—uploaded as individual files), and 20 references. The study design, detailed methods, and/or supporting data should be included in Online Supplementary Material (each file uploaded separately).
Clinical Trials
Word limit: 4,000 words (22,400 characters) maximum including spaces and abstract but excluding references, tables, and figures. Abstract: 250 words (1,500 characters) maximum including spaces. Results: Include headings about what is being tested in each individual experiment.
References: no limit.
Figures/tables: no limit. However, additional figures and tables may be considered as supplements for web-only publication.
Disclosure statement required.
Data Sharing Statement—Large biological datasets
Kidney International follows the ICMJE's data sharing statement policy for all clinical trials. To foster transparency, we require you to state the availability of your data in your manuscript. This may be a requirement of your funding body or institution. If your data are unavailable to access or unsuitable to post, you will need to indicate why, for example by stating that the research data are confidential. The statement will appear with your published article. For more information, visit the Data Statement page.
Full-length reports of current research in either basic or clinical science.
Please read the Special Notice Regarding Clinical Trials below.
Special notice regarding clinical trials
As defined by the International Committee of Medical Journal Editors (ICMJE), a clinical trial is any research project that prospectively assigns human subjects to intervention and comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. A medical intervention is any intervention used to modify a health outcome and includes but is not limited to drugs, surgical procedures, devices, behavioral treatments, and process-of-care changes. A trial must have at least one prospectively assigned concurrent control or comparison group in order to trigger the requirement for registration. Nonrandomized trials are not exempt from the registration requirement if they meet the above criteria.
All clinical trials must be registered in a public registry prior to submission. The journal follows the trials registration policy of the ICMJE (http://www.icmje.org) and considers only trials that have been appropriately registered before submission, regardless of when the trial closed to enrollment. Acceptable registries must meet the following ICMJE requirements:
be publicly available, searchable, and open to all prospective registrants;
have a validation mechanism for registration data; and
be managed by a not-for-profit organization.
Examples of registries that meet these criteria include:
the registry sponsored by the United States National Library of Medicine (http://www.clinicaltrials.gov),
the International Standard Randomized Controlled Trial Number Registry (http://www.controlled-trials.com),
the Cochrane Renal Group Registry (http://www.cochrane-renal.org), and
the European Clinical Trials Database (https://eudract.ema.europa.eu).
The trial registry number for eligible papers will be collected during the submission process.
Randomized Controlled Trials (RCTs) must adhere to the CONSORT statement (CONsolidated Standards Of Reporting Trials), and submissions must be accompanied by a completed CONSORT checklist (uploaded as a related manuscript file). Further information can be found at http://www.consort-statement.org.
Commentary (by invitation only)
Word limit: 1,500 words (8,400 characters) maximum including spaces and abstract but excluding references.
Title: 115 characters maximum including spaces.
Abstract: 75 words (420 characters) maximum.
References: 9 maximum including the article discussed.
Figures/tables: 1 figure required (will be redrawn).
Commentaries discuss a paper published in a specific issue and should set the problems addressed by the paper in the wider context of the field. Disclosure statement required.
Technical Note
Word limit: 1,500 words (8,400 characters) maximum including abstract but excluding references, tables, and figures.
Abstract: 250 words (1,500 characters) maximum including spaces.
References: 20 maximum.
Disclosure statement required.
Examples of appropriate subject matter include descriptions of new laboratory or clinical methods, new apparatus, or critical modifications of established techniques. Organization of Technical Notes should be the same as for regular manuscripts.
Letter to the Editor
Word limit: 250 words (1,500 characters) maximum including spaces.
Abstract: no abstract required for this manuscript type.
References: 4 maximum.
Figures/tables: up to 1.
Letters to the Editor will be considered for publication, subject to editing. Letters must contain information critical to a certain area or must be confirmatory of data recently published in Kidney International. A Letter must reference the original source, and a Response to a Letter must reference the Letter in the first few paragraphs, as well as the original source. Letters can use an arbitrary title, but a Response must cite the title of the Letter: e.g., Response to [title of Letter]. All Letters must contain a title page including title, all authors' names and affiliations, and corresponding author contact information.
Note that KI does not accept Letters to the Editor regarding Nephrology Digest articles.
Editorial (by invitation only)
Word Limit: 1,600 words (8,960 characters) maximum including spaces.
Abstract: no abstract required for this manuscript type.
Keywords: 3–6.
References: 5 maximum.
Proposals for Editorials may be submitted; authors should only send an outline of the proposed paper for initial consideration.
……
更多详情：
https://www.kidney-international.org/content/authorinfo
